Altogether, T21 is a novel potent inhibitor of STAT3 transcription factor that significantly decreases survivin levels, which may sensitize cancer cells to apoptosis and may enhance the apoptotic effect induced by traditional chemotherapeutic drugs in lung cancer patients. Here, BIRC5 is linked to lung cancer.